Pacific Biosciences of California Inc (NASDAQ: PACB) is a life sciences instrumentation company that develops and commercializes DNA sequencing systems based on its Single Molecule, Real-Time (SMRT) sequencing technology. Revenue comes from instrument sales, consumables sold on a per-run basis, and service contracts tied to its installed base of sequencing systems. The filing excerpts provided do not contain sufficient detail to characterize market position, segment revenue percentages, customer counts, named competitors, geographic mix, or capital structure with the specificity required for grounded disclosure. Accordingly, those elements are omitted from this description pending review of complete filing content.

Revenue model

Instrument sales, consumable reagents consumed on a per-run basis, and service/support contracts. The filing excerpts provided do not include revenue breakdowns by stream or fiscal period.

Products and services

SMRT sequencing instruments and related consumable reagents and service contracts. Specific product names and SKUs are not supported by the provided excerpts.

Customers and end markets

The provided filing excerpts do not specify customer types, end markets, or customer concentration metrics.

Value-chain role

Instrument and reagent manufacturer; direct supplier to genomics research and clinical laboratories.

Geographic exposure

The provided filing excerpts do not specify geographic revenue mix or operating footprint.

Source: SEC 10-K, filed 2026-02-25

Industry: Laboratory Analytical Instruments Peers: 10X Genomics Inc Adaptive Biotechnologies Corp Neogenomics Inc Azenta Inc Cytek Biosciences Inc MaxCyte Inc NS Wind Down Co., Inc. Sotera Health Co Thermo Fisher Scientific Inc